• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Du Pont to sell in vitro diagnostics unit

Article

Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of

Du Pont has agreed to sell its in vitro diagnostics business toDade International of Deerfield, IL. The unit manufactures andsells products for clinical chemistry and immunodiagnostic testingand had 1994 sales of $326 million, according to Du Pont, of Wilmington,DE.

The sale is part of Du Pont's plan to divest its Medical Productsbusinesses in order to pay for the repurchase of stock from Seagram(SCAN 6/7/95). The sale does not involve Du Pont's medical imagingfilm and PACS operations, however. Du Pont expects to announcea buyer for those businesses in the next four to six weeks.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.